Short answer
BALCHEM CORP (BCPC) filed its Q1 2026 10-Q quarterly report on Apr 30, 2026 for the quarter ended Mar 31, 2026. Quarterly revenue was $271M (up 8.1% year over year) with net income of $40M.
Q1 2026 key financials · XBRL
- Revenue
- $271M
- +8.1% YoY
- Net income
- $40M
- +8.7% YoY
- Operating margin
- 20.5%
- Gross margin
- 37.3%
- EPS (diluted)
- $1.25
- +10.6% YoY
Source: XBRL data from the BALCHEM CORP (BCPC) Q1 2026 10-Q on SEC EDGAR. USD.
BALCHEM CORP Q1 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Revenue $270.709M, up 8.1% YoY from $250.519M
- Operating margin 20.5% vs 20.4%; gross margin 37.3% vs 35.2%
- Best segment Specialty Products: operating earnings $11.935M, up 24.5%; worst growth Other and Unallocated: earnings down 13.5% to $(2.021)M
- Operating cash flow $40.061M, up 9.9%; cash $72.873M vs $74.570M at December 31, 2025
- Capital deployment: $30.769M dividends, $15.690M share repurchases, $6.252M capital investments; geopolitical tensions and tariffs remain headwinds
Risk Factors
- No material changes to risk factors identified since the December 31, 2025 Form 10-K
- Carried-forward regulatory, legal, operational, competitive, and financial risks unchanged from the 2025 Form 10-K
- No newly triggered risk factor disclosed for the quarter ended March 31, 2026
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other BALCHEM CORP quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.